Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy.
Overview & Synopsis
Open access biomedical research article published in J Immunother Cancer.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy. |
|---|---|
| Author / Organization | Yu Y, Liu Y, Zhang X, Yang W, Hou S, Yu W, Zhang F, Yu B, Hu Z, Wu Z, Huang S, Wang J |
| Subject & Discipline | J Immunother Cancer |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-42137 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |